Table of Contents

company-logo

Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also develops EDP1867, an inactivated investigational oral biologic, which is in Phase 1b for the treatment of inflammatory diseases; EDP2939, an extracellular vesicle investigational oral biologic for the treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Evelo Biosciences Dividend Announcement

• Evelo Biosciences does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Evelo Biosciences dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Evelo Biosciences Dividend History

Evelo Biosciences Dividend Yield

Evelo Biosciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Evelo Biosciences stock? Use our calculator to estimate your expected dividend yield:

Evelo Biosciences Financial Ratios

P/E ratio-0.00
PEG ratio-0.00
P/B ratio-0.00
ROE91.90%
Payout ratio0.00%
Current ratio0.48
Quick ratio0.48
Cash Ratio0.43

Evelo Biosciences Dividend FAQ

Does Evelo Biosciences stock pay dividends?
Evelo Biosciences does not currently pay dividends to its shareholders.
Has Evelo Biosciences ever paid a dividend?
No, Evelo Biosciences has no a history of paying dividends to its shareholders. Evelo Biosciences is not known for its dividend payments.
Why doesn't Evelo Biosciences pay dividends?
There are several potential reasons why Evelo Biosciences would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Evelo Biosciences ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Evelo Biosciences has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Evelo Biosciences a dividend aristocrat?
Evelo Biosciences is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Evelo Biosciences a dividend king?
Evelo Biosciences is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Evelo Biosciences a dividend stock?
No, Evelo Biosciences is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Evelo Biosciences stocks?
To buy Evelo Biosciences you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Evelo Biosciences stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.